Methods 5, 553559
Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity
Institutional review board Not applicable
This includes TB-500 10mg, BPC-157 10mg, all ipamorelin formats (5mg and 10mg), all CJC-1295 formats (With and Without DAC), all tesamorelin formats (5mg and 10mg), all sermorelin formats (2mg and 5mg), GHK-CU 50mg and 100mg, MT-1 10mg, MT-2 10mg, MOTS-C 10mg and 40mg, and AOD-9604 5mg and 10mg
The multi-use preservation window is particularly valuable for comparative GHRH analogue research protocols requiring repeated compound withdrawal across dose-response and time-course studies
doi:10.1128/Spectrum.00743-21 94